Clinical Usefulness of Antimicrobial Susceptibility Test for Helicobacter pylori | Zendy

Heungsup Sung | Zendy; HeeJung Chung | Zendy; MiNa Kim | Zendy; Gin Hyug Lee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Usefulness of Antimicrobial Susceptibility Test for Helicobacter pylori

Author(s) -

Heungsup Sung,

HeeJung Chung,

MiNa Kim,

Gin Hyug Lee

Publication year - 2006

Publication title -

annals of laboratory medicine

Language(s) - English

Resource type - Journals

eISSN - 2234-3814

pISSN - 2234-3806

DOI - 10.3343/kjlm.2006.26.3.179

Subject(s) - metronidazole , clarithromycin , helicobacter pylori , etest , amoxicillin , medicine , drug resistance , antibiotic resistance , antimicrobial , antibiotics , combination therapy , regimen , gastroenterology , microbiology and biotechnology , biology

Antimicrobial resistance of Helicobacter pylori is considered as the main cause of failure of eradication therapy. Because resistance to metronidazole has been reported in 25.8% to 66.2% of H. pylori, a combination of proton pump inhibitors (PPI), amoxicillin, and clarithromycin is currently recommended as a primary therapy. We investigated the prevalence of antimicrobial resistance to the primary drugs and the impact of antimicrobial resistance on eradication rates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research